Invests in
Sectors:
Min Investment:
$100,000.00Max Investment:
$5,000,000.00Target Investment:
$1,500,000.00
Skills
Education
- TJ
- HU
Lists including George
Investments
Clasp Therapeutics
Total Funding: $150M
Haystack Oncology
Total Funding: $56M
Anagenex
Total Funding: $30M
Octant Bio
Total Funding: $120M
Pheast Therapeutics
Total Funding: $76M
DNA Script
Total Funding: $470M
Sensei Biotherapeutics
Total Funding: $59M
Spiral Therapeutics
Total Funding: $6M
Work Experience
Co-Founder & Managing Partner
2020
Founded Catalio in 2020, to invest exclusively in breakthrough life sciences companies around the globe, founded by the world's leading scientist-entrepreneurs.
2014 - 2020
General Partner
2014 - 2020
Initially joined as an Analyst and then promoted to Partner at Camden Partners, a private equity firm that spun out of T. Rowe Price, where co-founded Camden Nexus, investing in breakthrough biomedical tech companies coming out of the labs of world-renowned scientist-entrepreneurs at Johns Hopkins.
2011 - 2011
Analyst - Project Finance
2011 - 2011
Constellation Energy Group (former NYSE: CEG), was the only Baltimore-based Fortune 500 company. CEG was an energy producer, trader, and distributor that operated over 35 power plants and was one of the top electricity producers in the US. In 2012, it was acquired by (NYSE: EXC) for $7.9 billion.